Evidence map›Paper›PMID 40710682›Full record

ReviewGels (Basel, Switzerland)2025

Dual-Drug Delivery Systems Using Hydrogel-Nanoparticle Composites: Recent Advances and Key Applications.

Moon Sup Yoon, Jae Min Lee, Min Jeong Jo, Su Jeong Kang, Myeong Kyun Yoo, So Yeon Park, Sunghyun Bong, Chan-Su Park, Chun-Woong Park, Jin-Seok Kim and 3 more

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. CRISPR-driven strategies to disrupt methicillin-resistantFrontiers in cellular and infection microbiology · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Moon Sup YoonCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Jae Min LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Min Jeong JoDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 66047, USA.
Su Jeong KangCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Myeong Kyun YooCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
So Yeon ParkCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Sunghyun BongCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Chan-Su ParkCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0000-0003-4968-8304
Chun-Woong ParkCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0000-0001-5329-8443
Jin-Seok KimDrug Information Research Institute (DIRI), College of Pharmacy, Sookmyung Women's University, Seoul 04310, Republic of Korea.
Sang-Bae HanCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0000-0001-6656-6523
Hye Jin LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Dae Hwan ShinCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.ORCID 0009-0009-6023-9930

Funding

Ministry of Education 2021RIS-001Ministry of Education NRF-2022R1C1C1007107Ministry of Science and ICT RS-2025-02273102
6 · The paper itself

Abstract

Dual-drug delivery systems using hydrogel-nanoparticle composites have emerged as a versatile platform for achieving controlled, targeted, and efficient delivery of two distinct therapeutic agents. This approach combines the high loading capacity and tunable release properties of hydrogels with the enhanced stability and targeting ability of nanoparticles, providing synergistic benefits in various biomedical applications. While significant progress has been made, previous research has primarily focused on single-drug systems or simple co-delivery strategies, often lacking precise spatial and temporal control. This gap underscores the need for more sophisticated composite designs that enable programmable, multi-phase release. This review discusses representative fabrication methods, including physical embedding, covalent integration, and layer-by-layer assembly, to offer insights into practical implementation strategies. Also we present recent studies focusing on key applications-including wound healing, cancer therapy, infection prevention, transplant immunosuppression, and tissue regeneration-with an emphasis on composite design and formulation strategies, types of hydrogels and nanoparticles, and mechanisms of dual-drug release and evaluation. Recent advances in nanoparticle engineering and hydrogel formulation have enabled precise control over drug release and improved therapeutic outcomes. Dual-drug delivery systems using hydrogel-nanoparticle composites present a promising approach for overcoming the limitations of conventional monotherapy and achieving synergistic therapeutic effects. Ongoing research continues to optimize the design, efficacy, and safety of these systems, paving the way for their clinical translation.

Indexed as

controlled drug releasedual-drug deliveryhydrogel–nanoparticle compositespolymer-based hydrogelssynergistic therapeutic effects

Identifiers

PMID40710682
PMCPMC12294678

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.